Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.Edwards Life ( EW) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, Edwards Life rose $1.25 (1.8%) to $70.86 on average volume. Throughout the day, 1,544,505 shares of Edwards Life exchanged hands as compared to its average daily volume of 1,543,200 shares. The stock ranged in a price between $69.00-$71.03 after having opened the day at $69.66 as compared to the previous trading day's close of $69.61. Other companies within the Health Services industry that increased today were: Uroplasty ( UPI), up 36.0%, Organovo Holdings ( ONVO), up 14.5%, CombiMatrix Corporation ( CBMX), up 8.5% and American Caresource Holdings ( ANCI), up 7.7%.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.7 billion and is part of the health care sector. Shares are down 22.8% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Edwards Life a buy, no analysts rate it a sell, and 9 rate it a hold. TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.